The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs

Influenza viruses (IVs) threaten global human health due to the high morbidity, infection, and mortality rates. Currently, the influenza drugs recommended by the FDA are oseltamivir, zanamivir, peramivir, and baloxavir marboxil. Notably, owing to the high variability of IVs, no drug exists that can...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanbai, Huo, Shanshan, Yin, Zhe, Tian, Zuguang, Huang, Fang, Liu, Peng, Liu, Yue, Yu, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653855/
https://www.ncbi.nlm.nih.gov/pubmed/37610204
http://dx.doi.org/10.1128/mbio.01273-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653855/
https://www.ncbi.nlm.nih.gov/pubmed/37610204
http://dx.doi.org/10.1128/mbio.01273-23

Ejemplares similares